Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart valve patients test easier blood thinner

NCT ID NCT07456085

Summary

This study is testing if a newer blood thinner called rivaroxaban is as safe and effective as the standard drug warfarin for people with mechanical heart valves. It focuses on patients in Pakistan who have difficulty getting the regular blood tests required for warfarin. Sixty participants will be followed for one year to compare rates of blood clots and bleeding events between the two medications.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VALVULAR HEART DISEASE PATIENTS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Rawalpindi Institute of Cardiology

    Rawalpindi, Punjab Province, 46000, Pakistan

Conditions

Explore the condition pages connected to this study.